In vivo CAR-T therapy transforms customized treatments into universal medicines
A collaborative team led by Professor Huji Xu from Naval Medical University, China, together with Professors Xuanming Yang and Yujia Cai at Shanghai Jiao Tong University, China, published a comprehensive review in Volume 2, article number 33 of the journal Immunity & Inflammation on August 31, 2026.
Read original article on The Medical News →Related news
-
Cystic fibrosis: Triple therapy is particularly effective in early childhood
United Kingdom
-
Virtual reality and classical music help to reduce blood pressure in patients in emergency department
United Kingdom
-
Drones could speed up delivery of automated external defibrillators to patients suffering cardiac arrest
United Kingdom
-
Steatotic liver disease risk scores compared for predicting cirrhosis
United Kingdom
-
Tapping the power of cryo-ET to visualize how molecular machines interact inside cells
United Kingdom
-
UC researcher receives funding to study bone complications in people with sickle cell disease
United Kingdom
-
Aga's restaurant in Houston is number one in the world for Uber Eats deliveries
United States
-
UM birding program can help stroke survivors with aphasia
United Kingdom